← All stocks

NEUROCRINE BIOSCIENCES INC

NBIX Scheduled selling only

CIK 0000914475 #761 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$826.37K

$493.34K on a plan · $333.03K straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$826.37K

$0.00 against sales at will

By person

20 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ABERNETHY MATT

Chief Financial Officer

—

$363.28K (1) scheduled

−$363.28K

42,808

0.0421%

$6.73M

+34.1%

BENEVICH ERIC

Chief Commercial Officer

—

$333.03K (1) scheduled

−$333.03K

67,297

0.0662%

$10.58M

+40.0%

Boyer David W.

Chief Corp. Affairs Officer

—

$130.05K (1) scheduled

−$130.05K

8,722

0.0086%

$1.37M

+312.0%

GORMAN KEVIN CHARLES

Director

—

517,797

0.5094%

$81.40M

+0.6%

Gano Kyle

Chief Executive Officer

—

154,728

0.1522%

$24.32M

+14.0%

LYONS GARY A

Director

—

122,141

0.1202%

$19.20M

+2.6%

Lippoldt Darin

Chief Legal Officer

—

56,793

0.0559%

$8.93M

+42.9%

RASTETTER WILLIAM H

Director

—

43,678

0.0430%

$6.87M

+16.5%

POPS RICHARD F

Director

—

37,798

0.0372%

$5.94M

+19.6%

ROBERTS EIRY

Chief Medical Officer

—

35,640

0.0351%

$5.60M

+50.3%

Cooke Julie

Chief Human Resources Officer

—

24,025

0.0236%

$3.78M

+29.3%

Onyia Jude

Chief Scientific Officer

—

22,647

0.0223%

$3.56M

+64.9%

Delaet Ingrid

Chief Regulatory Officer

—

18,289

0.0180%

$2.87M

+629.5%

SHERWIN STEPHEN A

Director

—

14,860

0.0146%

$2.34M

−43.9%

MORROW GEORGE J

Director

—

10,386

0.0102%

$1.63M

+147.3%

Mercier Johanna

Director

—

6,853

0.0067%

$1.08M

+226.3%

POON CHRISTINE A

Director

—

4,753

0.0047%

$747.16K

—

Sharp Shalini

Director

—

4,088

0.0040%

$642.63K

+311.3%

Keswani Sanjay Chandru

Chief Medical Officer

—

3,281

0.0032%

$515.77K

—

Norwalk Leslie V

Director

—

2,430

0.0024%

$381.99K

+144.5%

Individual transactions

Insider

Date

Role

Action

Price

Amount

ABERNETHY MATT

14 Sep 2026

Chief Financial Officer

Sold on a plan

2,311

$157.20

$363.28K

Boyer David W.

14 Sep 2026

Chief Corp. Affairs Officer

Sold on a plan

826

$157.45

$130.05K

Show all 3 transactions →

NEUROCRINE BIOSCIENCES INC

By person

Individual transactions

What was left out